New-Born Screening Market Analysis
The global new-born screening market is likely to touch USD 1545.98 million at a 13.33% CAGR between 2019- 2025, according to the recent report by Market Research Future (MRFR). New-born screening, simply put, is a practice to test each new-born for some possibly fatal or harmful disorders, which are otherwise not obvious at birth. It includes the usage of different devices during the screening procedure. Diseases like tyrosinemia, cystic fibrosis, sickle cell disease, galactosemia, congenital hypothyroidism, phenylketonuria, and other such disorders are screened using different new-born screening devices.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/6561
Various factors are adding to the global new-born screening market growth. Such factors, according to the new MRFR report, include increasing neonatal population, rising cases of diseases in new-borns, and growing investments on healthcare by government organizations. Additional factors adding market growth include technological advances, and rising cases of neonatal conditions.
On the contrary, the scarcity of trained professionals, the unreliability of new-born screening tests, and the lack of proper healthcare infrastructure are factors that may limit the new-born screening market growth over the forecast period.
New-Born Screening Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global new-born screening market report based on end user, test type, technology, and product.
By products, the new-born screening market is segmented into assay kits and reagents & assay kits. Of these, the instruments segment will lead the market over the forecast period.
By technology, the new-born screening market is segmented into hearing screening technology, immunoassays and enzymatic assays, pulse oximetry, electrophoresis, DNA assays, and tandem mass spectrometry. Of these, the tandem mass spectrometry segment will dominate the market over the forecast period.
By test type, the new-born screening market is segmented into a hearing screening test, urine test, critical heart disease (CCHD), and dry blood spot test. Of these, the dry blood spot test segment will have a major share in the market over the forecast period.
By end user, the new-born screening market is segmented into diagnostic centers, maternity & specialty clinics, hospitals, & others. Among these, hospitals will have the lions share in the market over the forecast period.
New-Born Screening Market Regional Analysis
Based on the region, the new-born screening market report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period for the burgeoning demand for such screening and the rising awareness.
The new-born screening market in Europe is predicted to have the second-largest share over the forecast period for the growing awareness about new-born disorders and related screening programs, increasing cases of neonatal disorders, and technological advances such as health insurance and National Health Service.
The new-born screening market in the APAC region is likely to grow at a fast pace over the forecast period for the improving healthcare infrastructure, rising mortality rates of neonates, and increasing neonatal population. Besides, the increasing cases of neonatal disorders, especially in developing countries, & support from the government are also adding market growth in the region.
The new-born screening market in the MEA is likely to have a slow growth over the forecast period for strong support from the government and developing healthcare infrastructure. Besides, the increasing awareness about new-born screening is also adding market growth.
New-Born Screening Market Key Players
Leading players profiled in the global new-born screening market report include Thermo Fisher Scientific Inc. (US), ZenTech SA (Belgium), Trivitron Healthcare (India), GENERAL ELECTRIC (Boston), Medtronic PLC (Ireland), Bio-Rad Laboratories, Inc. (US), Agilent Technologies Inc. (US), Masimo Corporation (US), Natus Medical Incorporated (US), Waters (US), PerkinElmer Inc. (US), and SCIEX (US).
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/new-born-screening-market-6561
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.